February 7, 2021 General information Many thanks to Jonathan Jarry @CrackedScience for an informative discussion about science miscommunication. #ScienceUpFirst #GoScience
February 4, 2021 Allergy/Immunology Lancet posts Oxford Vaccine Group preprint study on how the timing of the booster dose of its Oxford-AZ vaccine affects the immune response and efficacy for people 18-55 years of age.
February 3, 2021 Bioengineering Excellent review of myths of enlisting more companies to make mRNA vaccine by @DerekLowe. Bespoke machines, processes & tech, multiple supply chains, a myriad of Sci & Eng expertise & steps needed before mass production. Many pharma companies can’t do it.
January 25, 2021 Biomedical Engineering Two positive steps forward for treatment and testing of coronavirus.
January 20, 2021 Allergy/Immunology California investigating why less than 10 people at one specific vaccination site (but not anywhere else) developed possible allergic reactions from specific lot of Moderna vaccine. Was it the vaccine or some other source?
January 18, 2021 Apps and diagnosis Study reports that Apple watches require further evaluation to determine their ability to predict COVID-19 infection due to small study size, self-reported data, and a small number of infections within the group.
January 8, 2021 Infectious Disease A post hoc ergo propter hoc moment: Quebec City care home outbreak after COVID-19 vaccination was not because vaccine did not work; it did not have enough time to do so. It also did not cause the outbreak; you cannot get Covid-19 from the vaccine.
December 29, 2020 Clinical Research What are some of the concerns about the new variant of SARS-CoV-2 with respect to transmission, number of fatalities, and its impact on children?
December 15, 2020 Health Policy With the beginning of COVID-19 vaccination in Canada, some are concerned people will prematurely ease up on public health measures before we achieve herd immunity.
December 14, 2020 Science and Media Reporting Vaccine safety. No, the Pfizer vaccine was not rushed to market.
